MedPath

Sucralfate

Sucralfate Tablets

Approved
Approval ID

ae58c382-c1cf-4ebf-9c97-bdff0682df8b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 12, 2020

Manufacturers
FDA

Greenstone LLC

DUNS: 825560733

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sucralfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code59762-0401
Application NumberNDA018333
Product Classification
M
Marketing Category
C73605
G
Generic Name
Sucralfate
Product Specifications
Route of AdministrationORAL
Effective DateNovember 20, 2023
FDA Product Classification

INGREDIENTS (6)

MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SUCRALFATEActive
Quantity: 1 g in 1 1
Code: XX73205DH5
Classification: ACTIB
FD&C RED NO. 3Inactive
Code: PN2ZH5LOQY
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sucralfate - FDA Drug Approval Details